Xconomy’s Digital Events →
Jon Mirsalis (left), who leads infectious disease research at SRI, and his team in the lab. Photo courtesy of SRI.
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.